Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of Congo

This study reveals a high level of drug-resistant tuberculosis in Brazzaville, with previous TB treatment being a significant risk factor. The findings underscore the need to strengthen molecular surveillance and TB management and control measures in the Republic of Congo.

Authors

Institutions

Publication Details

Journal
Annals of Clinical Microbiology and Antimicrobials
Published
2025-05-09
DOI
https://doi.org/10.1186/s12941-025-00786-8
Citations
4
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
5.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of Congo

Timothy D. McHugh, Jean Claude Djontu, Micheska Epola Dibamba Ndanga, Rhett Chester Mevyann et al.
4 citations
Annals of Clinical Microbiology and Antimicrobials
Tuberculosis Research and Epidemiology
5.58
article

Drug-resistant tuberculosis profiles among patients presenting at the antituberculosis center of Brazzaville, Republic of Congo

Timothy D. McHugh, Jean Claude Djontu, Micheska Epola Dibamba Ndanga, Rhett Chester Mevyann, Christopher Mebiame Biyogho, Jabar Babatunde Pacome Agbo Achimi Abdul, Freisnel Hermeland Mouzinga, Christevy Vouvoungui, Darrel Ornelle Elion Assiana, Alimuddin Zumla, Francine Ntoumi, Alain Maxime Mouanga, Michel Illoye Ayet, Martin P. Grobusch, F.H. Okemba Okombi, Guy Arnault Rogue Mfoumbi Ibinda, Ayôla Akim Adégnika, Véronique Penlap, Breli Bonheur Ngouama, Alain Brice Vouidibio Mbozo, Mita Naomie Merveille Dello, Lemercier Khunell Siele, Roélie Foxie Mizele Kitoti
article en
4 citations

Abstract

This study reveals a high level of drug-resistant tuberculosis in Brazzaville, with previous TB treatment being a significant risk factor. The findings underscore the need to strengthen molecular surveillance and TB management and control measures in the Republic of Congo.

Annals of Clinical Microbiology and AntimicrobialsVol. 24(1)
Université de Yaoundé I (CM), Royal Tropical Institute (NL), Centre de Recherche Médicales de Lambaréné (GA), Fondation Congolaise Pour La Recherche Médicale (CG), Centre Hospitalier et Universitaire de Brazzaville (CG), German Center for Infection Research (DE), Wildlife Conservation Society Congo (CG), UCL Biomedical Research Centre (GB), Programme National Multisectoriel de Lutte contre le sida (CD), University College London (GB), Marien Ngouabi University (CG), University of Tübingen (DE)
Alexander von Humboldt-Stiftung, National Institute for Health and Care Research, Fondation Mérieux, Horizon 2020 Framework Programme, Universitätsklinikum Tübingen, European and Developing Countries Clinical Trials Partnership
Good health and well-being
Openalex Percentile: Top 4%
Tuberculosis Research and Epidemiology
5.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.